Leila Alland - 07 Sep 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role: Chief Medical Officer
Signature: /s/ Winston Kung, by power of attorney
Issuer symbol: PMVP
Transactions as of: 07 Sep 2021
Net transactions value: -$102,765
Form type: 4
Filing time: 08 Sep 2021, 16:22:43 UTC
Previous filing: 10 Aug 2021
Next filing: 10 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PMVP	Common Stock	Options Exercise	$15,210	+3,900		$3.90	3,900	07 Sep 2021	Direct
transaction	PMVP	Common Stock	Sale	$117,975	-3,900	-100%	$30.25	0	07 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PMVP	Employee Stock Option (right to buy)	Options Exercise	$0	-3,900	-1.1%	$0.000000	353,950	07 Sep 2021	Common Stock	3,900	$3.90	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.
F2	One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter.